Comunicato Stampa dell’EMA sui medicinali contenenti Pioglitazone
Disponibile on line aggiornamento sulla sospensione dei medicinali a base di Pioglitazone in Francia, mentre prosegue la revisione a livello Europeo
Undefined
Disponibile on line aggiornamento sulla sospensione dei medicinali a base di Pioglitazone in Francia, mentre prosegue la revisione a livello Europeo
Two large, randomized controlled trials showed an increased incidence of high-grade prostate cancer with finasteride and dutasteride treatment.
Patients taking simvastatin 80 mg daily have an increased risk of myopathy, including rhabdomyolysis, which can damage the kidneys and lead to kidney failure which can be fatal.
UPDATE 06/08/2011. Churchill Medical Systems/Vygon recalled Skin-Prep Wipes used in Convenience Kits. Use of contaminated alcohol prep pads, alcohol swabs or alcohol swabsticks could lead to life-threatening infections.
Product contains analogs of Sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Inhalation of the plastic strands may cause respiratory compromise, which could result in serious illness or death.
Potential for serious anaphylactic reaction in patients with known hypersensitivity to beta-lactam or penicillin products.
Thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer.
No increase in risk of cancer with ARB blood pressure drugs.
Agenzie regolatorie
AIFA - Agenzia italiana del farmaco
EMA - European Medicines Agency
FDA - MedWatch Safety Alerts
Centri universitari
80.211.154.110